Showing results 93 to 112 of 174
< previous
next >
| Issue Date | Title | Author(s) |
| 2019 | Investigation of potential anticarcinogenic effects of corilagin in lung cancer cells | Rencüzoğulları, Çağla; Çinçin, Zeynep Birsu; İplik, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia |
| 2009 | The involvement of ceramide metabolizing genes and their products in docetaxel induced apoptosis in human prostate cancer cells | Başsoy, Esen Yonca |
| 2014 | JAK/STAT Signalling pathway genes in the regulation of tyrosine kinase inhibitors induced and clinical process in chronic myeloid leukemia patients | Kiraz, Yağmur ; Kartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, I.; Özcan, Mehmet Ali; Saydam, Göksel; Şahin, Fahri; Avcu, Ferit; Ural, Ali Uğur; Ünal, Ali; Baran, Yusuf |
| 2019 | La médecine de précision en oncologie: challenges, enjeux et nouveaux paradigmes | Cox, Stephanie; Rousseau-Tsangaris, Marina; Abou-Zeid, Nancy; Dalle, Stephane; Leurent, Pierre; Cutivet, Arnaud; Baran, Yusuf |
| Aug-2012 | Macromolecular changes in nilotinib resistant k562 cells; An in vitro study by fourier transform infrared spectroscopy | Ceylan, Çağatay ; Camgöz, Aylin; Baran, Yusuf |
| Jul-2016 | Major apoptotic mechanisms and genes involved in apoptosis | Kiraz, Yağmur ; Adan, Aysun ; Kartal Yandım, Melis; Baran, Yusuf |
| 2007 | Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells | Baran, Yusuf ; Ural, Ali Uğur; Gündüz, Ufuk |
| 2010 | The mechanisms responsible for Nilotinib resistance in human chronic myeloid leukemia cells | Camgöz, Aylin |
| Jun-2013 | Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance | Camgöz, Aylin; Gençer, Emel Başak; Ural, Ali Uğur; Baran, Yusuf |
| 2015 | Mesenchymal stem cells administered intraperitoneally have a potent effects on the experimental allergic airway disease | Işık, S.; Adan, Aysun ; Karaman, M.; Kiray, M.; Bağrıyanık, H. A.; Çağlayan-Sözmen, S.; Uzuner, N.; Baran, Yusuf |
| Aug-2011 | Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma | Fırıncı, Fatih; Karaman, Meral; Baran, Yusuf ; Bağrıyanık, Alper; Arıkan Ayyıldız, Zeynep; Kiray, Müge; Kozanoglu, İlknur; Yılmaz, Osman; Uzuner, Nevin; Karaman, Özkan |
| 2015 | The microarray gene profiling analysis of acute promyelocytic leukemia cells in response to fisetin and hesperetin | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 2023 | MicroRNAs and long non-coding RNAs as novel targets in anti-cancer drug development | Çetinkaya, Melisa; Baran, Yusuf |
| 2018 | A minimally invasive transfer method of mesenchymal stem cells to the intact periodontal ligament of rat teeth: a preliminary study | Gül Amuk, Nisa; Kurt, Gökmen; Kartal Yandım, Melis; Adan, Aysun ; Baran, Yusuf |
| Apr-2013 | miR-17 in imatinib resistance and response to tyrosine kinase inhibitors in chronic myeloid leukemia cells | Fıratlıgil, Burcu ; Biray Avcı, Çığır; Baran, Yusuf |
| Feb-2016 | A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib | Kartal Yandım, Melis; Ceylan, Çağatay ; Elmas, Efe; Baran, Yusuf |
| Jul-2016 | Molecular mechanisms of drug resistance and its reversal in cancer | Kartal Yandım, Melis; Adan Gökbulut, Aysun ; Baran, Yusuf |
| Aug-2014 | Molecular mechanisms of quercitrin-induced apoptosis in non-small cell lung cancer | Çinçin, Zeynep Birsu; Ünlü, Miray ; Kıran, Bayram; Bireller, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia |
| 2014 | Multidrug resistance in chronic myeloid leukemia | Ünlü, Miray ; Kiraz, Yağmur ; Kacı, Fatma Necmiye; Özcan, Mehmet Ali; Baran, Yusuf |
| Feb-2009 | Multidrug resistance mediated by MRP1 gene overexpression in breast cancer patients | Abaan, Ogan Demir; Mutlu, Pelin Kaya; Baran, Yusuf ; Atalay, Can; Gündüz, Ufuk |
